Literature DB >> 12142311

Human African trypanosomiasis.

August Stich1, Paulo M Abel, Sanjeev Krishna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12142311      PMCID： PMC1123723          DOI： 10.1136/bmj.325.7357.203

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  New drugs for the treatment of human African trypanosomiasis: research and development.

Authors:  J Keiser; A Stich; C Burri
Journal:  Trends Parasitol       Date:  2001-01

2.  Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial.

Authors:  C Burri; S Nkunku; A Merolle; T Smith; J Blum; R Brun
Journal:  Lancet       Date:  2000-04-22       Impact factor: 79.321

3.  The use of the acridine orange QBC technique in the diagnosis of African trypanosomiasis.

Authors:  J W Bailey; D H Smith
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Nov-Dec       Impact factor: 2.184

4.  Localization of variable antigens in the surface coat of Trypanosoma brucei using ferritin conjugated antibody.

Authors:  K Vickerman; A G Luckins
Journal:  Nature       Date:  1969-12-13       Impact factor: 49.962

5.  African sleeping sickness in tourists returning from Tanzania: the first 2 Italian cases from a small outbreak among European travelers.

Authors:  Diego Ripamonti; Marco Massari; Claudio Arici; Ermanno Gabbi; Claudio Farina; Maria Brini; Carlo Capatti; Fredy Suter
Journal:  Clin Infect Dis       Date:  2001-11-19       Impact factor: 9.079

Review 6.  Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1998

7.  Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness.

Authors:  J Pepin; F Milord; C Guern; B Mpia; L Ethier; D Mansinsa
Journal:  Lancet       Date:  1989-06-03       Impact factor: 79.321

8.  The phenomenon of treatment failures in Human African Trypanosomiasis.

Authors:  R Brun; R Schumacher; C Schmid; C Kunz; C Burri
Journal:  Trop Med Int Health       Date:  2001-11       Impact factor: 2.622

Review 9.  Human African trypanosomiasis: an emerging public health crisis.

Authors:  D H Smith; J Pepin; A H Stich
Journal:  Br Med Bull       Date:  1998       Impact factor: 4.291

10.  A comparison of parasitological methods for the diagnosis of gambian trypanosomiasis in an area of low endemicity in Côte d'Ivoire.

Authors:  P Truc; J W Bailey; F Doua; C Laveissière; D G Godfrey
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Jul-Aug       Impact factor: 2.184
View more
  34 in total

1.  Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense in vitro growth.

Authors:  Yuliya V Mishina; Sanjeev Krishna; Richard K Haynes; John C Meade
Journal:  Antimicrob Agents Chemother       Date:  2007-03-05       Impact factor: 5.191

2.  African Trypanosomiasis: Changing Epidemiology and Consequences.

Authors:  Jean-Paul Chretien; Bonnie L Smoak
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

3.  African sleeping sickness.

Authors:  Francesco Checchi; Michael P Barrett
Journal:  BMJ       Date:  2008-03-05

4.  RNA-editing-associated protein 1 null mutant reveals link to mitochondrial RNA stability.

Authors:  Jennifer Hans; Stephen L Hajduk; Susan Madison-Antenucci
Journal:  RNA       Date:  2007-04-06       Impact factor: 4.942

5.  Global metabolic responses of mice to Trypanosoma brucei brucei infection.

Authors:  Yulan Wang; Jürg Utzinger; Jasmina Saric; Jia V Li; Jean Burckhardt; Stephan Dirnhofer; Jeremy K Nicholson; Burton H Singer; Reto Brun; Elaine Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

6.  Erythrina abyssinica prevents meningoencephalitis in chronic Trypanosoma brucei brucei mouse model.

Authors:  Johnson Nasimolo; Stephen Gitahi Kiama; Peter Karuri Gathumbi; Andrew Ndegwa Makanya; John Maina Kagira
Journal:  Metab Brain Dis       Date:  2014-01-23       Impact factor: 3.584

7.  Mouse infection and pathogenesis by Trypanosoma brucei motility mutants.

Authors:  Neville K Kisalu; Gerasimos Langousis; Laurent A Bentolila; Katherine S Ralston; Kent L Hill
Journal:  Cell Microbiol       Date:  2014-01-08       Impact factor: 3.715

8.  Antitrypanosomal activities of fluoroquinolones with pyrrolidinyl substitutions.

Authors:  Elizabeth Nenortas; Tomasz Kulikowicz; Christian Burri; Theresa A Shapiro
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

9.  Adenosine Kinase of T. b. Rhodesiense identified as the putative target of 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine using chemical proteomics.

Authors:  Sabine Kuettel; Marc Mosimann; Pascal Mäser; Marcel Kaiser; Reto Brun; Leonardo Scapozza; Remo Perozzo
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25

10.  East African trypanosomiasis in a pregnant traveler.

Authors:  Behzad Nadjm; Chris Van Tulleken; Douglas Macdonald; Peter L Chiodini
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.